DR. ROBERT PAUL SAMBURSKY, M.D.
Medical Practice at Manatee Ave, Bradenton, FL
License number
Florida ME0092802
Category
Medical Practice
Type
Ophthalmology
Address
Address
217 Manatee Ave E, Bradenton, FL 34208
Phone
(941) 748-1818
(941) 746-1055 (Fax)
(941) 746-1055 (Fax)
Personal information
See more information about ROBERT PAUL SAMBURSKY at radaris.comName
Address
Phone
1281 Gulf Of Mexico Dr UNIT 10, Longboat Key, FL 34228
13946 Wood Duck Cir, Lakewood Ranch, FL 34202
13946 Wood Duck Cir, Bradenton, FL 34202
1427 Tamiami Cir, Sarasota, FL 34239
1515 Sun City Center Blvd, Sun City Center, FL 33573
Professional information
See more information about ROBERT PAUL SAMBURSKY at trustoria.com
In Situ Lysis Of Cells In Lateral Flow Immunoassays
In Situ Lysis Of Cells In Lateral Flow Immunoassays
US Patent:
8614101, Dec 24, 2013
Filed:
Jul 14, 2009
Appl. No.:
12/502662
Inventors:
Robert W. VanDine - Montoursville PA, US
Uma Mahesh Babu - Bradenton FL, US
Robert P. Sambursky - Bradenton FL, US
Uma Mahesh Babu - Bradenton FL, US
Robert P. Sambursky - Bradenton FL, US
Assignee:
Rapid Pathogen Screening, Inc. - Sarasota FL
International Classification:
G01N 33/558
US Classification:
436514, 422420, 422425, 4352877, 4352879, 435805, 435810, 435970, 435973, 436169, 436177, 436530, 436810
Abstract:
Devices and methods incorporate lysis agents into a point-of-care testing device. The sample is loaded, and then the sample travels until it encounters a lysis agent. The lysis agent is preferably pre-loaded onto the collection device. In a preferred embodiment, the initially lysis agent is localized between the sample application zone and the conjugate zone. The lysis agent is preferably soluble or miscible in the sample transport liquid, and the lysis agent is solubilized and activated upon contact with the sample transport liquid. The sample transport liquid then contains both lysis agent in solution or suspension and sample components in suspension. Any lysis-susceptible components in a sample, then being exposed in suspension to the lysis agent, are themselves lysed in situ. The running buffer then carries the analyte, including any lysis-freed components, to the detection zone.
Multiplanar Lateral Flow Assay With Diverting Zone
Multiplanar Lateral Flow Assay With Diverting Zone
US Patent:
2013023, Sep 5, 2013
Filed:
Mar 7, 2013
Appl. No.:
13/788616
Inventors:
Robert P. Sambursky - Bradenton FL, US
Peter Condon - Longboat Key FL, US
Robert W. VanDine - Montoursville PA, US
Peter Condon - Longboat Key FL, US
Robert W. VanDine - Montoursville PA, US
Assignee:
RAPID PATHOGEN SCREENING, INC. - Sarasota FL
International Classification:
G01N 33/53
US Classification:
435 5, 436501, 435 71, 435 79, 4352872, 422 69
Abstract:
A lateral flow device includes a sample compressor and a test strip comprising a diverting zone. The diverting zone, which may include a barrier and/or a gap or ditch, stops or impedes flow. Flow is reinitiated and diverted into an alternate plane by compression of a sample compressor. Flow returns to the original, lateral plane, at the end of the diverting zone.
Lateral Flow Assays With Time Delayed Components
Lateral Flow Assays With Time Delayed Components
US Patent:
2013001, Jan 17, 2013
Filed:
Sep 19, 2012
Appl. No.:
13/622791
Inventors:
Robert W. VanDine - Montoursville PA, US
Robert P. Sambursky - Bradenton FL, US
Robert P. Sambursky - Bradenton FL, US
Assignee:
RAPID PATHOGEN SCREENING, INC. - Sarasota FL
International Classification:
G01N 33/53, C12M 1/40
US Classification:
435 79, 422 69, 436501, 4352872
Abstract:
A lateral flow device may include one or more enhancement elements, where the enhancement elements bind to the analyte sandwich to increase a detection signal in the test zone. In preferred embodiments, some or all of the enhancement elements are encapsulated.
Method For The Rapid Diagnosis Of Targets In Human Body Fluids Using Undiluted Samples
Method For The Rapid Diagnosis Of Targets In Human Body Fluids Using Undiluted Samples
US Patent:
8647890, Feb 11, 2014
Filed:
Feb 8, 2010
Appl. No.:
12/701799
Inventors:
Franz Aberl - Kranzberg, DE
Marcus Scheibenzuber - München, DE
Robert P. Sambursky - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Jose S. Sambursky - Johnson City NY, US
Marcus Scheibenzuber - München, DE
Robert P. Sambursky - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Jose S. Sambursky - Johnson City NY, US
Assignee:
Rapid Pathogen Screening, Inc. - Sarasota FL
International Classification:
G01N 33/558, G01N 33/53
US Classification:
436514, 435 71
Abstract:
More particularly, the present invention relates to a method for the detection of a target, e. g. pathogen in a human body fluid wherein a body fluid sample is collected with a swab member.
Lateral Flow Nucleic Acid Detector
Lateral Flow Nucleic Acid Detector
US Patent:
2012026, Oct 18, 2012
Filed:
Jun 25, 2012
Appl. No.:
13/531993
Inventors:
Robert P. Sambursky - Bradenton FL, US
Uma Mahesh Babu - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Uma Mahesh Babu - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Assignee:
RAPID PATHOGEN SCREENING, INC. - Sarasota FL
International Classification:
C12Q 1/68, G01N 21/25, G01N 21/76, G01N 21/64
US Classification:
435 612
Abstract:
Point-of-care binding assays include at least one target nucleic acid binding in a multiplex structure with at least one sequence in a partner nucleic acid associated with a label, due to complementary base pairings between at least one sequence in the target nucleic acid and at least one sequence in the partner nucleic acid. The assays overcome the inherent deficiencies of antibody-protein antigen assays. In a preferred embodiment, color tagged nucleic acid sequences are used to bind a complementary target nucleic acid. The tagged nucleic acid sequences are preferably made from deoxyribonucleotides, ribonucleotides, or peptide nucleotides.
Methods And Devices For Using Mucolytic Agents Including N-Acetyl Cysteine (Nac)
Methods And Devices For Using Mucolytic Agents Including N-Acetyl Cysteine (Nac)
US Patent:
2012025, Oct 11, 2012
Filed:
May 3, 2012
Appl. No.:
13/463126
Inventors:
Uma Mahesh Babu - Bradenton FL, US
Robert P. Sambursky - Bradenton FL, US
Robert P. Sambursky - Bradenton FL, US
Assignee:
RAPID PATHOGEN SCREENING, INC. - Sarasota FL
International Classification:
G01N 33/558, C12M 1/34, G01N 1/28, G01N 33/573
US Classification:
435 74, 4352872, 436514, 435 71, 436175, 422 69
Abstract:
Devices and methods incorporate mucolytic agents into a point-of-care testing device. The sample is loaded, and then the sample travels until it encounters one or more lysis agents and/or mucolytic agents. The mucolytic agent is preferably pre-loaded onto the collection device. In a preferred embodiment, the mucolytic agent is localized between the sample application zone and the conjugate zone. In embodiments with a sample compressor, one or more mucolytic agents may be pre-loaded and dried on the sample compressor, the sample collector, in various locations on the test strip, or in the running buffer.
Multiplanar Lateral Flow Assay With Sample Compressor
Multiplanar Lateral Flow Assay With Sample Compressor
US Patent:
8609433, Dec 17, 2013
Filed:
Dec 2, 2010
Appl. No.:
12/958454
Inventors:
Robert P. Sambursky - Bradenton FL, US
Uma Mahesh Babu - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Ganga V. Kanaujia - Bradenton FL, US
Thomas Orsini - Sarasota FL, US
Uma Mahesh Babu - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Ganga V. Kanaujia - Bradenton FL, US
Thomas Orsini - Sarasota FL, US
Assignee:
Rapid Pathogen Screening, Inc. - Sarasota FL
International Classification:
G01N 33/563, G01N 33/558, G01N 33/553
US Classification:
436513, 436514, 436525, 436807
Abstract:
A sample compressor applies pressure to a sample collector and a sample application zone of a test strip to transfer a sample from the sample collector and a binding partner of an analyte to the sample application zone in a lateral flow device. At least one of the binding partners of the analyte is not located on the test strip prior to use of the lateral flow device. The test strip may be a universal test strip with no molecule that specifically binds the analyte is located on the test strip. The sample compressor may be a universal sample compressor also with no molecule that specifically binds the analyte on the sample compressor. The lateral flow device may also include one or more enhancement elements, where the enhancement elements bind to the analyte sandwich to increase a detection signal in the test zone.
Apparatus For The Rapid Diagnosis Of Targets In Human Body Fluids
Apparatus For The Rapid Diagnosis Of Targets In Human Body Fluids
US Patent:
2014008, Mar 20, 2014
Filed:
Nov 20, 2013
Appl. No.:
14/084973
Inventors:
Marcus Scheibenzuber - Munchen, DE
Robert P. Sambursky - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Jose S. Sambursky - Long Boat Key FL, US
Robert P. Sambursky - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Jose S. Sambursky - Long Boat Key FL, US
Assignee:
RAPID PATHOGEN SCREENING, INC. - Sarasota FL
International Classification:
G01N 33/569
US Classification:
4352872
Abstract:
More particularly, the present invention relates to a method for the detection of a target, e.g. pathogen in a human body fluid wherein a body fluid sample is collected with a swab member.
Lateral Flow Assays
Lateral Flow Assays
US Patent:
2013021, Aug 15, 2013
Filed:
Mar 8, 2013
Appl. No.:
13/790229
Inventors:
Robert P. Sambursky - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Robert W. VanDine - Montoursville PA, US
Assignee:
Rapid Pathogen Screening, Inc. - Sarasota FL
International Classification:
G01N 33/53
US Classification:
435 619, 436501
Abstract:
Assays and methods including mobile tagged single stranded nucleic acid reagents pre-loaded on an analysis device, which are preferably tagged, but not labeled and are complementary to a strand (preferably the anti-sense strand in double stranded DNA targets) of the target nucleic acid. The assay also includes a running buffer that includes a dye or other detectable label that nonspecifically binds only to double stranded nucleic acids. In addition, the analysis device includes a detection zone including one or more test zones that have an immobilized tag that binds to the tag on the mobile nucleic acid reagent.
Lateral Flow Assays
Lateral Flow Assays
US Patent:
2011008, Apr 14, 2011
Filed:
Dec 1, 2010
Appl. No.:
12/957683
Inventors:
Uma Mahesh Babu - Bradenton FL, US
Robert P. Sambursky - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Robert P. Sambursky - Bradenton FL, US
Robert W. VanDine - Montoursville PA, US
Assignee:
RAPID PATHOGEN SCREENING, INC. - Sarasota FL
International Classification:
C12Q 1/68, G01N 33/50
US Classification:
435 6, 436 94
Abstract:
Assays and methods including mobile tagged single stranded nucleic acid reagents pre-loaded on an analysis device, which are preferably tagged, but not labeled and are complementary to a strand (preferably the anti-sense strand in double stranded DNA targets) of the target nucleic acid. The assay also includes a running buffer that includes a dye or other detectable label that nonspecifically binds only to double stranded nucleic acids. In addition, the analysis device includes a detection zone including one or more test zones that have an immobilized tag that binds to the tag on the mobile nucleic acid reagent.